May 2018

Important New Products

• Dupixent (dupilumab (rch)) is a fully human recombinant monoclonal antibody that inhibits ...(more)
• Odomzo (sonidegib) is a selective Smoothened (Smo) antagonist. Smo is a G-protein coupled ...(more)
• Vosevi (sofosbuvir/velpatasvir/voxilaprevir) is a fixed dose combination tablet containing the ...(more)

New Contraindications

• Duratocin (carbetocin) should not be used in patients with cardiovascular disease, especially ...(more)
• Ubistesin and Ubistesin Forte (articaine hydrochloride/adrenaline (epinephrine) (as ...(more)

Active Ingredient Naming Changes

In this release, MIMS Australia will be including the following INNs (International Non-proprietary Names) as well as Australian Approved Names (AANs) as part of our push to support the Therapeutic Goods Administration (TGA) active ingredient name changes project.  

MIMS will begin referring to these ingredients by their new names, however, users may continue to search by the old AANs if preferred. 

To contact MIMS editorial please email To enquire about purchasing a product please contact MIMS Customer service on 1800 800 629 or email For more information about MIMS, please see

Copyright © 2018 MIMS Australia Pty Ltd. All rights reserved.
Our mailing address is:
MIMS Australia, Level 2, 1 Chandos Street, St Leonards NSW 2065, Phone: 1800 800 629